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Pregnancy is a physiological event for utmost women [1]. Almost 20–30% of the adult population and more than 5–8% of all pregnancies in the world suffer from hypertension 
(HTN) and 5–22% of all pregnancies develop some kinds of medical 
problems due to HTN [2-6]. Pregnancy-induced hypertension (PIH) 
includes hypertensive disorders peculiar to pregnancy that have 
their onset during pregnancy and subsides completely following 
delivery. This includes pre-eclampsia, eclampsia, and gestational 
HTN. The overall incidence of PIH is 7% [4]. PIH is known to be 
associated with increased perinatal morbidity and mortality due to 
various prenatal and natal factors in addition to the adverse effects 
of drugs used in the management of it. PIH is also associated with an 
increased incidence of prematurity and small for date babies, which 
also affects the incidence of perinatal mortality and morbidity [5].
In India, perinatal mortality rate (PNMR) in PIH is high as 
the emphasis is still on maternal salvage, and there is lack of 
tertiary care centers dealing with premature and low-birth-weight 
infants [7-9]. Hence, the present study was undertaken to determine 
the extent of perinatal problems in our district hospital and to 
evaluate the prognostic significance of various factors associated 
with PIH on perinatal outcome and determine its effects.
MATERIALS AND METHODS
It was a hospital-based study, and convenient sampling technique 
was used. All births to mothers with PIH, which took place 
from March 2018 to February 2019 in District Hospital Tumkur, 
Karnataka, were included. Mothers who were diagnosed to have 
PIH as per the criteria laid down by the American College of 
Obstetricians and Gynecologists were included in the study after 
taking their consent.
A detailed maternal history was taken regarding age, 
parity, antenatal care, HTN in previous pregnancy, and history 
suggestive of severity of HTN such as blurring of vision, 
headache, and epigastric pain. Mothers with other major illness 
such as diabetes, heart disease, and renal disease were excluded 
from the study. Details of labor with reference to the mode of 
delivery, indications, and mode of termination were included. 
Details of treatment used to control HTN and convulsion 
including cumulative dose, route of administration, and time of 
delivery were noted. Ocular fundus was examined in all cases 
to grade hypertensive changes in all cases. The investigations 
carried out in mother were the estimation of hemoglobin, urine 
for albumin, sugar and microscopy, blood urea, and serum 
creatinine.
In all cases, the placenta was examined soon after the delivery. 
Both fetal and maternal surfaces were examined. The number 
and extent of placental infarcts was recorded. All live babies 
were examined in the delivery room for Appearance, Pulse, 
Grimace, Activity, and Respiration (APGAR) score, and details 
of resuscitation if needed were recorded meticulously. After a 
few hours of delivery, a detailed examination of a newborn was 
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carried out for anthropometric measurement in terms of weight, 
height, and head circumference. Gestational age was determined 
by maternal dates and by Dubowitz criteria 12–24 h after birth. 
If a discrepancy of more than 2 weeks existed, the gestational 
age was assigned from the Dubowitz maturity score. According 
to the scoring system, infants were classified as pre-term or full 
term. Infants were also classified as appropriate or small for 
gestational age (SGA) according to the Lubchenco intrauterine 
growth curves.
Data were entered in Excel sheet, and the analysis was done 
in Epi Info. Percentages and figures were calculated. Mean and 
standard deviation were calculated for quantitative data. Chi 
square was calculated for proportions. p<0.05 was considered 
significant.
RESULTS
Among the 2325 deliveries which took place, 200 mothers had PIH 
(8.6%), of which 6.8% (157) had pre-eclampsia and rest (1.8%) 
suffered from eclampsia. The most common reason for morbidity 
because of PIH was thrombocytopenia (34.28%) and other 
minor conditions affecting were respiratory depression (11, 7%), 
hypotonia (10, 6.3%), hypoglycemia (5, 3.2%), intraventricular 
hemorrhage (13, 1.9%),  Disseminated intravascular coagulation 
(DIC) (6, 3.8%), and transient tachypnea of the newborn (3, 2.5%). 
The details of relationship of neonatal morbidity to severity of 
HTN are discussed in Table 1.
There was statistically significant difference regarding grades 
of PIH and perinatal outcomes. The neonatal deaths and intrauterine 
deaths were significantly increased as the degree of HTN became 
more severe. The details are given in Table 2.
The details of the relationship of perinatal outcome with 
systolic and diastolic blood pressure are mentioned in Table 3.
Neonatal morbidity increased as the dosage of magnesium 
sulfate increased Table 4. Hypotonia, ileus, lethargy, and 
respiratory depression increased with the increasing dose of 
magnesium sulfate.
DISCUSSION
In the present study, the incidence of preterm was 31% which 
was high in eclampsia (63). This was significantly higher than 
the hospital incidence of prematurity as compared to 23% noted 
by Githa and Gopal [5,7] and 58.1% by Sibai (54%) [10,11]. The 
Table 1: Neonatal morbidity in relation to severity of HTN
Pregnancy-induced 
HTN grading
Cases Live 
births
Pre-term Small for 
gestational 
age
HMD MAS Patent ductus 
arteriosus of 
prematurity
Birth 
asphyxia
Septicemia Thrombo 
cytopenia
Gest HTN 27 27 0 0 0 1 0 1 1 0
Mild 42 40 5 0 3 0 1 4 2 4
Severe 88 64 27 23 15 11 5 11 14 30
Eclampsia 43 27 17 5 4 6 5 14 8 20
Total 200 158 49 (31%) 28 (17.7%) 22 (13.9%) 18 (11.4%) 11 (22.4%) 30 (19%) 25 (15.8%) 54 (34.28%)
HTN: Hypertension
Table 2: Perinatal outcome in relation to severity of HTN
Pregnancy-induced 
HTN grading
Cases (%) Live births Pre-term (%) Term Small for 
gestational age (%)
IUD/SB (%) Neonatal deaths (%)
Gestational HTN 27 (13.5) 27 0 27 0 0 0
Mild 42 (21.0) 40 5 (21.5) 35 0 2 (4.8) 3 (7.5)
Severe 88 (44.0) 64 37 (42.2) 37 23 (26.1) 24 (27.3) 13 (20.3)
Eclampsia 43 (21.5) 27 17 (62.8) 10 5 (11.6) 16 (37.2) 11 (40.7)
Total 200 158 49 (31.0) 109 28 (14.0) 42 (21.0) 27 (17.1)
p<0.05 p<0.001 p<0.001
HTN: Hypertension
Table 3: Perinatal outcome in relation to maternal BP
Perinatal outcome Systolic BP in mmHg (%) Diastolic BP in mmHg (%) p Value
140–165 166–190 191–215 215–240 90–100 101–110 111–120 121–130 131–140
Number 118 (59) 68 (34) 11 (5.5) 3 (1.5) 67 (33.5) 59 (29.5) 40 (20.0) 23 (11.5) 12 (6.0)
Pre-term 26 (24) 26 (24) 26 (24) 26 (24) 6 (9.2) 18 (38.3) 16 (57.1) 6 (50.0) 3 (50.0) p<0.001
Term 70 (75.2) 70 (75.2) 70 (75.2) 70 (75.2) 59 (90.8) 29 (61.7) 12 (42.9) 6 (50.0) 3 (50.0)
Small for gestational age 14 (13.3) 14 (13.3) 14 (13.3) 14 (13.3) 1 (1.5) 14 (29.8) 4 (14.3) 7 (58.3) 2 (33.3)
IUD 13 (11) 13 (11.0) 13 (11.0) 13 (11.0) 2 (3.0) 12 (20.3) 12 (30.0) 10 (45.5) 6 (50.0) p<0.001
Neonatal deaths 14 (13.3) 14 (13.3) 14 (13.3) 14 (13.3) 4 (6.2) 6 (12.8) 7 (25.0) 3 (30.0) 6 (100.0) p<0.001
BP: Blood pressure
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incidence of SGA was 17% as compared to be 29% by chesley 
et al. [6] and 20% by Sibai (54%) [10,11]. Patent ductus arteriosus 
of prematurity was 22.5% which was higher in eclampsia. In PIH, 
severe constriction leads to ischemic changes in various organs, 
endothelial damage, and deposition of platelet anti-fibrin thrombi; 
the incidence may be related to maternal disease.
Hypotonia was seen in 6.3% of cases and ileus in 5.06% 
because of treatment with magnesium sulfate sand when 
cumulative doses exceeded 40 g, it leaded to hypermagnesemia 
with neonatal complications (56) [12,13]. PNMR in the study is 
345/1000 which is higher than in general PNMR of the hospital 
(77.4%) [14], it was significantly higher when compared to other 
studies. The reason for such a high perinatal mortality may be due 
to delayed referral. Increase in perinatal morbidity and mortality 
was observed with rise in systolic and diastolic blood pressure 
with systolic pressure more than 220 mmHg; there was 100% 
incidence of prematurity [15].
The time of delivery in women who develop severe PIH in 
earlier part of pregnancy is difficult. The potential benefit of 
increased fetal maturity from delaying delivery must be balanced 
against the risk of hypoxia and sudden intrauterine death and severe 
growth restriction [16]. Hence, high-risk patients of PIH should 
be appropriately counseled and must be managed with adequate 
neonatal intensive care facilities to improve the outcome. The study 
had certain limitations as it was a hospital-based study; hence, 
the results of the study could not be generalized. Hence, further 
community-based study should be done using larger sample size.
CONCLUSION
PIH is a multisystem disease and threat to the well-being 
of the mother and her unborn child. Characterization of the 
neonatal consequences of maternal HTN is complicated by the 
administration of antihypertensive and anticonvulsant medications 
to the mother. Thus, the fetal outcome might be influenced by 
both maternal disease and pharmacological intervention.
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Table 4: Maternal administration of magnesium sulfate and associated neonatal morbidity
Cumulative dose grams No. of patients Hypotonia Ileus Delayed stooling >48 h lethargy Respiratory depression
<20 16 0 0 0 0 0
21–40 21 2 1 9 4 2
41–60 8 8 7 7 6 5
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